Evidence
Base? Caveat Emptor!
Earl P. Steinberg, Bryan R.
Luce
Moral
Hazard in Medicare Coverage for Prescription Drugs
D. Shea, J. Terza, B. Stuart,
B. Briesacher
Reporting
of Drug Expenditures in the MCBS
J. Poisal
Risk
Adjustment of Medicare Capitation Payments Using
the CMS-HCC Model
G. Pope, et al
Methods for
Analyzing Healthcare Utilization and Costs
P. Diehr, D. Yanez,
A. Ash, M. Hornbrook, D. Y. Lin
Adjusting
Capitation Rates Using Objective Health
Measures and Prior
Utilization
J. Newhouse, W. Manning, E.
Keeler, E. Sloss
Estimating
Causal Effects from Large Data Sets Using
Propensity Scores
D. Rubin
Principles
for Modeling Propensity Scores in Medical
Research: A Systematic
Review of the Literature
S. Weitzen, et al
Impact
of Prescription Coverage
on Hospital and Physician
Costs: A Case Study of
Medicare Beneficiaries with
Chronic Obstructive
Pulmonary Disease
B. Stuart, et al
Can
Econometrics Rescue Epidemiology?
S. Mennemeyer
Does
Endogeneity Matter? A Comparison of Epimerical
Analysis with and without
Control for Endogeneity
N. Zohoori
An
Introduction to Instrumental Variables for
Epidemiologists
S. Greenland
Effects
of Medicaid Drug Payment Limits on Admissions to
Hospitals and Nursing
Homes
S. Soumerai
Assessing the Sensitivity of Regression Results to
Unmeasured Confounders in Observational Studies
Lin, D.Y., Psaty, B.M., Kronmal, R.A.
Moral Hazzard in Prescription Drugs and Medicare
Shea, D.G., Terza, J.V., Stuart, B.C., Briesacher, B.
Econometric Approaches to Epidemiologic Data:
Relating Endogeneity and Unobserved Heterogeneity to Confounding
N. Zohoori, D. A. Savitz
